1. Immune Responses against Marek's Disease Virus Infection
- Author
-
S.Y. Cha, J.B. Park, H.K. Jang, and Y.M. Park
- Subjects
Marek's disease ,animal structures ,animal diseases ,viruses ,Cancer ,Disease ,Biology ,medicine.disease ,biology.organism_classification ,Virology ,Virus ,Vaccination ,Pathogenesis ,Immune system ,Susceptible individual ,hemic and lymphatic diseases ,Immunology ,medicine - Abstract
Marek's disease virus (MDV) is a highly cell-associated, lymphotropic α-herpesvirus that causes paralysis and neoplastic disease in chickens. The disease has been controlled by vaccination which was provided the first evidence for a malignant cancer being controlled by an antiviral vaccine. Marek's disease pathogenesis is complex, involving cytolytic and latent infection of lymphoid cells and oncogenic transformation of CD4 + T cells in susceptible chickens. MDV targets a number of different cell types during its life cycle. Lymphocytes play an essential role, although within them virus production is restricted and only virion are produced. Innate and adaptive immune responses develop in response to infection, but infection of lymphocytes results in immunosuppressive effects. Hence in MDV-infected birds, MDV makes its host more vulnerable to tumour development as well as to other pathogens. All chickens are susceptible to MDV infection, and vaccination is essential to protect the susceptible host from developing clinical disease. Nevertheless, MDV infects and replicates in vaccinated chickens, with the challenge virus being shed from the feather-follicle epithelium. The outcome of infection with MDV depends on a complex interplay of factors involving the MDV pathotype and the host genotype. Host factors that influence the course of MD are predominantly the responses of the innate and adaptive immune systems, and these are modulated by: age at infection and maturity of the immune system; vaccination status; the sex of the host; and various physiological factors.
- Published
- 2008